semaglutide elisa kit fda banning compounded July 29, 2024: FDA issued new alert about compounded semaglutide – Partnership for Safe Medicines Semaglutide (Ozempic®) ELISA Kit |

It may also be possible that Ozempic disrupts metabolic and hormonal signalling pathways, such as the insulin/IGF-1 pathway

Another study examined the neuroprotective effects of the GLP-1R agonist liraglutide in an Mitochondrial permeability transition pore (MPTP)-induced PD model, where MPTP exposure led to mitochondrial dysfunction, impaired autophagy, and increased cell apoptosis [74]

Theres no interaction between the two medications that would require a change in timing or dose

34:45: Ford notes, that although the causes for sarcopenia are multifactorial, it does seem that one of the drivers of sarcopenia is a general anabolic hormone resistance, very much like insulin resistance that we discussed earlier